Genomic medicine is already helping more people receive answers about their health conditions through better diagnosis, treatment, and support. By volunteering to take part in research, you'll be making a difference to NHS patients and the future of genomic medicine.
Research in this community will focus on the development, refinement, validation and application of bioinformatics approaches to interrogate data in the NGRL and maximise the ability for clinically relevant discovery. It will facilitate the open exchange and sharing of computational ideas and methods, including powerful machine learning approaches. It will also ensure best practices in clinical interpretation analysis, work with disease groups to provide access to world-leading statistical and computational data analysis expertise; and provide training and support a world-leading workforce in support of genomic-based healthcare.
Professor Chris Yau
University of Oxford
Dr David Morris
King's College London
Research in this community will focus on the development, refinement, validation and application of bioinformatics approaches to interrogate data in the NGRL and maximise the ability for clinically relevant discovery. It will facilitate the open exchange and sharing of computational ideas and methods, including powerful machine learning approaches. It will also ensure best practices in clinical interpretation analysis, work with disease groups to provide access to world-leading statistical and computational data analysis expertise; and provide training and support a world-leading workforce in support of genomic-based healthcare.
Professor Chris Yau
University of Oxford
Dr David Morris
King's College London
The impact of collecting and using patient data isn't always straightforward, so we're always listening to public opinion and leading the ethics debate.
Watch this short video on the public dialogue around screening the whole genomes of newborns.
The NHS Genomic Medicine Service (GMS) Research Collaborative is a partnership between the NHS GMS, Genomics England and the National Institute of Health Research (NIHR) to support genomic research and development on a national scale.
Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion
Lucy Hare, Jamie Trotman, Patrick Tarpey, et al.
Adaptive Long-Read Sequencing Reveals GGC Repeat Expansion in ZFHX3 Associated with Spinocerebellar Ataxia Type 4
Zhongbo Chen, Emil K Gustavsson, Hannah Macpherson, et al.
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme
Alona Sosinsky, John Ambrose, William Cross, et al.
